Toward the discovery of dual HCMV–VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides

Add time:09/09/2019    Source:sciencedirect.com

The need for novel therapeutic options to fight herpesvirus infections still persists. Herein we report the design, synthesis and antiviral evaluation of a new family of non-nucleoside antivirals, derived from 1-[ω-(4-bromophenoxy)alkyl]uracil derivatives – previously reported inhibitors of human cytomegalovirus (HCMV). Introduction of the N-(4-phenoxyphenyl)acetamide side chain at N3 increased their potency and widened activity spectrum. The most active compounds in the series exhibit submicromolar activity against different viral strains of HCMV and varicella zoster virus (VZV) replication in HEL cell cultures. Inactivity against other DNA and RNA viruses, including herpes simplex virus 1/2, points to a novel mechanism of antiviral action.

We also recommend Trading Suppliers and Manufacturers of 1-(4-BROMOPHENOXY)-2-PROPANONE (cas 18621-22-2). Pls Click Website Link as below: cas 18621-22-2 suppliers

Prev:2,4,6-tris-4-(bromophenoxy)-1,3,5-triazine: a hexagonal host framework assembled with robust Br⋯Br trimer synthons
Next:Cobalt(II)–catalyzed C8H alkoxylation of 1-naphthylamine derivatives with alcohols)